News & Views
After another exciting year, Fabrice Allum, Managing Director at Porterhouse Insights, reflects on the benefits of cross-functional working for our pharmaceutical clients.
Porterhouse Medical Group is proud to announce the promotion of Alice Wright and Rebecca Thomas.
Porterhouse Medical Group is delighted to announce that we have strengthened our scientific expertise and boosted our creative capacity with four new starters.
Non-24-Hour Sleep–Wake Disorder (N24) is a rare, debilitating disorder that affects 55%–70% of the blind population and a small proportion of the sighted population. To help raise awareness for those affected by N24, this article explains the mechanism of the disorder, the extent to which it affects their lives, the difficulties in diagnosis and available treatments.
Gordon Muir-Jones, President of Porterhouse Medical US, is delighted to be co-moderating the ISMPP West Workshop on Ethics in Publications Practice.
At Porterhouse, we work hard to integrate the company values into everything we do. These values form our PATH and are reflected in our approach to the recruitment, training and well-being of our in-house teams of medical writers, account managers, event planners, designers and programmers.
At Porterhouse, we are very proud of our hard-working teams and are delighted to announce the double promotion of Sammy and Cat.